Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
GW Pharmaceuticals
Biotech
Encoded bags $135M to push 'precision gene therapy' into phase 1
Encoded Therapeutics raised $135 million to advance a precision gene therapy that could address more symptoms of Dravet syndrome than seizures.
Amirah Al Idrus
Jul 22, 2020 6:00am
After Dravet hiccup, Zogenix's Fintepla logs Lennox-Gastaut win
Feb 7, 2020 10:45am
Zogenix data blunder trips up FDA filing for epilepsy drug Fintepla
Apr 9, 2019 6:54am
Ovid, Takeda add 2 rare epilepsies to rare drug pact
Jul 18, 2018 10:56am
Chasing GW, Zogenix scores a win in second Dravet phase 3
Jul 12, 2018 9:10am
Kalytera's cannabis-based GVHD drug gathers steam
Jun 21, 2018 10:04am